Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 18,378 $ 27,873
Restricted cash 1,269 1,148
Accounts receivable, net of allowance of $112 and $98 at December 31, 2024 and December 31, 2023, respectively 21,591 21,005
Short-term investments 108,757 138,264
Prepaid expenses and other current assets 10,747 17,971
Total current assets 160,742 206,261
Non-current assets:    
Property and equipment, net 30,918 2,899
Intangible assets, net 13,653 20,519
Goodwill 41,050 40,373
Operating right-of-use asset 8,876 23,484
Other non-current assets 1,436 1,402
Total assets 256,675 294,938
Current liabilities:    
Accounts payable and accrued expenses 12,766 23,859
Deferred revenue 6,656 6,845
Operating lease liability, current 3,304 4,787
Total current liabilities 22,726 35,491
Non-current liabilities:    
Warrant liability 5,808 4,958
Operating lease liability, long-term 6,018 19,738
Deferred tax liability 185 451
Total liabilities 34,737 60,638
Commitments and Contingencies (Note 12)
Stockholders' Equity    
Preferred stock, $0.0001 par value, 2,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 0 0
Common stock, $0.0001 par value; 400,000,000 authorized; 79,419,028 and 75,131,425 shares issued at December 31, 2024 and December 31, 2023, respectively 7 7
Additional paid in capital 407,076 390,083
Accumulated other comprehensive income 1,753 3,964
Accumulated deficit (186,898) (159,754)
Total stockholders' equity 221,938 234,300
Total Liabilities and Stockholders' Equity $ 256,675 $ 294,938